arxiv
PublishedJune 18, 2026 at 4:00 AM
—neutral
TxBench-PP: Analyzing AI Agent Performance on Small-Molecule Preclinical Pharmacology
Publisher summary· verbatim
arXiv:2606.19245v1 Announce Type: new Abstract: Artificial intelligence (AI) agents promise to accelerate drug discovery by compressing interpretation and decision-making loops, but practical deployment requires trusted evaluation on realistic program decisions. We introduce TherapeuticsBench Precli
Stay posted· Newsletter
A 5-min weekly brief — top movers, price watch, story of the week.
Discussion
No replies yet. Be first.
Related coverage
More from ARXIV
arxivHuman-AI Agent Interaction in a Business Context2harxivMeasuring Curriculum Alignment across Topical Coverage, Competency, and Cognitive Depth: A Longitudinal Framework Applied to CS2013 and CS20232harxivREVEAL++: Differentiable Phenotypic Grouping for Vision-Language Retinal Modeling of Alzheimer's Disease Risk2harxivEmergent Alignment2hThe Bubble Brief
WEEKLYRead AI insights every Tuesday — top movers, new releases, story of the week.
Originally published on arxiv ↗